Paroxysmal Atrial Fibrillation
Rare Disease·MeSH: Atrial Fibrillation
Prevalence
1200.0 / 100K
Incidence
100.0 / 100K/yr
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Approved(1)
| Drug | Company |
|---|---|
| propafenone | Mylan II B.V. (MYL) |
Frequently asked questions
How many drugs are in development for Paroxysmal Atrial Fibrillation?
BioSniper tracks 1 drug in development for Paroxysmal Atrial Fibrillation across 1 company.
How many clinical trials target Paroxysmal Atrial Fibrillation?
There are 1 clinical trial targeting Paroxysmal Atrial Fibrillation tracked by BioSniper.
What is the prevalence of Paroxysmal Atrial Fibrillation?
The estimated prevalence of Paroxysmal Atrial Fibrillation is approximately 1200.0 per 100,000 population.
Deep-dive into Paroxysmal Atrial Fibrillation
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis